Historical Valuation
Catheter Precision Inc (VTAK) is now in the Fair zone, suggesting that its current forward PS ratio of 0.88 is considered Fairly compared with the five-year average of -0.28. The fair price of Catheter Precision Inc (VTAK) is between 0.28 to 2.13 according to relative valuation methord.
Relative Value
Fair Zone
0.28-2.13
Current Price：2.02
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Catheter Precision Inc (VTAK) has a current Price-to-Book (P/B) ratio of 0.49. Compared to its 3-year average P/B ratio of 0.25 , the current P/B ratio is approximately 96.81% higher. Relative to its 5-year average P/B ratio of 0.25, the current P/B ratio is about 96.81% higher. Catheter Precision Inc (VTAK) has a Forward Free Cash Flow (FCF) yield of approximately -288.21%. Compared to its 3-year average FCF yield of -429.33%, the current FCF yield is approximately -32.87% lower. Relative to its 5-year average FCF yield of -429.33% , the current FCF yield is about -32.87% lower.
P/B
Median3y
0.25
Median5y
0.25
FCF Yield
Median3y
-429.33
Median5y
-429.33
Competitors Valuation Multiple
AI Analysis for VTAK
The average P/S ratio for VTAK competitors is 0.26, providing a benchmark for relative valuation. Catheter Precision Inc Corp (VTAK.A) exhibits a P/S ratio of 0.88, which is 235.35% above the industry average. Given its robust revenue growth of 135.42%, this premium appears sustainable.
Performance Decomposition
AI Analysis for VTAK
1Y
3Y
5Y
Market capitalization of VTAK increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of VTAK in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is VTAK currently overvalued or undervalued?
Catheter Precision Inc (VTAK) is now in the Fair zone, suggesting that its current forward PS ratio of 0.88 is considered Fairly compared with the five-year average of -0.28. The fair price of Catheter Precision Inc (VTAK) is between 0.28 to 2.13 according to relative valuation methord.
What is Catheter Precision Inc (VTAK) fair value?
VTAK's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Catheter Precision Inc (VTAK) is between 0.28 to 2.13 according to relative valuation methord.
How does VTAK's valuation metrics compare to the industry average?
The average P/S ratio for VTAK's competitors is 0.26, providing a benchmark for relative valuation. Catheter Precision Inc Corp (VTAK) exhibits a P/S ratio of 0.88, which is 235.35% above the industry average. Given its robust revenue growth of 135.42%, this premium appears sustainable.
What is the current P/B ratio for Catheter Precision Inc (VTAK) as of Jan 09 2026?
As of Jan 09 2026, Catheter Precision Inc (VTAK) has a P/B ratio of 0.49. This indicates that the market values VTAK at 0.49 times its book value.
What is the current FCF Yield for Catheter Precision Inc (VTAK) as of Jan 09 2026?
As of Jan 09 2026, Catheter Precision Inc (VTAK) has a FCF Yield of -288.21%. This means that for every dollar of Catheter Precision Inc’s market capitalization, the company generates -288.21 cents in free cash flow.
What is the current Forward P/E ratio for Catheter Precision Inc (VTAK) as of Jan 09 2026?
As of Jan 09 2026, Catheter Precision Inc (VTAK) has a Forward P/E ratio of -0.17. This means the market is willing to pay $-0.17 for every dollar of Catheter Precision Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Catheter Precision Inc (VTAK) as of Jan 09 2026?
As of Jan 09 2026, Catheter Precision Inc (VTAK) has a Forward P/S ratio of 0.88. This means the market is valuing VTAK at $0.88 for every dollar of expected revenue over the next 12 months.